Trials / Conditions / Deep Vein Thrombosis (DVT)

Deep Vein Thrombosis (DVT)

19 registered clinical trials studyying Deep Vein Thrombosis (DVT) — 5 currently recruiting.

Status	Trial	Sponsor	Phase
Recruiting	Cleaner Long-tErm Assessment Registry - Venous Insights and Efficacy With eXtended Tracking NCT07102160	Argon Medical Devices	—
Recruiting	Progressive Gait Training After First-time Deep Venous Thrombosis: Clinical Effectiveness and Involved Mecanis NCT06909240	Hvidovre University Hospital	N/A
Active Not Recruiting	Effectiveness and Cost-effectiveness of VTE Prevention Strategies in Gynecological Surgery NCT07455253	Affiliated Hospital of Nantong University	—
Recruiting	Study of Risk Factors and Prediction of Blood Clots After Lung Cancer Surgery NCT07439991	The First Hospital of Jilin University	—
Completed	To Compare and Evaluate the Oral Bioavailability of Edoxaban 60 mg Film Coated Tablet With That of Lixiana® 60 NCT06930937	Humanis Saglık Anonim Sirketi	N/A
Completed	Improving Emergency Department Testing for Deep Vein Thrombosis NCT06195787	Dr. Kerstin de Wit	—
Completed	COMPARISON OF WARFARIN AND RIVAROXABAN IN THE TREATMENT OF LOWER LIMB DEEP VENOUS THROMBOSIS NCT07077954	Children Hospital and Institute of Child Health, Lahore	Phase 1
Completed	Nursing-Led Deep Vein Thrombosis Prevention in Neurosurgery NCT07330661	West China Hospital	N/A
Completed	Hokusai Study in Pediatric Patients With Confirmed Venous Thromboembolism (VTE) NCT02798471	Daiichi Sankyo	Phase 3
Completed	Direct Oral Anticoagulants (DOACs) Versus LMWH +/- Warfarin for VTE in Cancer NCT02744092	Alliance Foundation Trials, LLC.	N/A
Completed	Evaluation of Soluble Fibrin in Thrombosis Exclusion NCT02523937	Diagnostica Stago R&D	—
Completed	Cancer Venous Thromboembolism (VTE) NCT02073682	Daiichi Sankyo	Phase 3
Completed	Osteopathic Treatment and Deep Vein Thrombosis (DVT) NCT02205294	Nova Scotia Health Authority	N/A
Terminated	Below Knee DVT Study NCT03805672	Oregon Health and Science University	Phase 4
Completed	Treatment of Venous Thromboembolism (VTE) With Either Rivaroxaban or Current Standard of Care Therapy NCT02210819	Bayer	—
Recruiting	Lovenox 30 mg Twice Daily (BID) Versus 40 mg Once Daily (QD) NCT02342444	Oregon Health and Science University	Phase 4
Recruiting	VTEval Project - Prospective Cohort Studies to Evaluate and Improve Diagnostics, Management Strategies and Ris NCT02156401	Johannes Gutenberg University Mainz	—
Completed	Bemiparin as a Thromboprophylaxis After Gynaecological Surgeries NCT01630148	Hawler Medical University	N/A
Completed	Comparative Investigation of Low Molecular Weight (LMW) Heparin/Edoxaban Tosylate (DU176b) Versus (LMW) Hepari NCT00986154	Daiichi Sankyo	Phase 3